Several other research analysts have also weighed in on the company. Jefferies Financial Group initiated coverage on Demant A/S in a research report on Thursday, April 21st. They set a “buy” rating on the stock. JPMorgan Chase & Co. upped their price target on Demant A/S from 306.00 to 313.00 and gave the company a “neutral” rating in a research report on Wednesday, May 4th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Demant A/S has a consensus rating of “Hold” and an average target price of $311.00.
Demant A/S Price Performance
Shares of Demant A/S stock opened at $37.75 on Wednesday. Demant A/S has a 12-month low of $37.25 and a 12-month high of $59.30. The stock’s fifty day moving average is $38.76 and its 200-day moving average is $40.42.
About Demant A/S
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.
- Get a free copy of the StockNews.com research report on Demant A/S (WILLF)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Find and Profitably Trade Stocks at 52-Week Lows
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.